SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* WHEAT DOUGLAS D (Last) (First) (Middle) 180 STATE STREET SUITE 230 (Street) SOUTHLAKE TX 76092 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol AMN HEALTHCARE SERVICES INC [ AHS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 04/12/2012
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/12/2012		M		16,168	A	$5.81	46,210	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)							(2)	(6)	Common Stock	4,048		4,048	D
Restricted Stock Units	(1)							(3)	(6)	Common Stock	5,555		5,555	D
Stock Appreciation Rights	$18.03							(4)	04/12/2016	Common Stock	4,445		4,445	D
Stock Appreciation Rights	$24.95							(5)	04/18/2017	Common Stock	3,482		3,482	D
Stock Options (Right to buy)	$15.47							09/28/2006	09/28/2015	Common Stock	20,000		20,000	D
Restricted Stock Units	(1)							(7)	(6)	Common Stock	6,009		6,009	D
Stock Appreciation Rights	$16.18							(8)	04/08/2018	Common Stock	5,168		5,168	D
Restricted Stock Units	(1)							(9)	(6)	Common Stock	9,563		9,563	D
Stock Appreciation Rights	$6							(10)	04/09/2019	Common Stock	8,224		8,224	D
Restricted Stock Units	(1)							(11)	(6)	Common Stock	9,563		9,563	D
Stock Appreciation Rights	$8.83							(12)	04/13/2020	Common Stock	8,224		8,224	D
Restricted Stock Units	(1)	04/12/2012		M(14)			16,168	(13)	(6)	Common Stock	16,168	(1)	0	D

Explanation of Responses:

1. The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

2. The Restricted Stock Units were granted on April 18, 2007 and vest in the incremental amount of 33% on the earlier of(i) April 18, 2008 or (ii) the date of the Company's 2008 Annual Meeting of Stock holders ; 34% on the earlier of (i) April 18, 2009 or (ii) the date of the Company's 2009 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 18, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders. The Restricted Stock Units settle on the date of the director's termination of service with the Company.

3. The Restricted Stock Units were granted on April 12, 2006 and vest in the incremental amount of 33% on the earlier of (i) April 12, 2007 or (ii) the date of the Company's 2007 Annual Meeting of Stockholders; 34% on the earlier of(i) April 12,2008 or (ii) the date of the Company's 2008 Annual Meeting of Stockholders; and 33% on the earlier of(i) April 12, 2009 or(ii) the date of the Company's 2009 Annual Meeting of Stockholders. The Restricted Stock Units settle on the date of the director's termination of service with the Company.

4. The Stock Appreciation Rights were granted on April 12, 2006 and vest on the earlier of (i) April 12, 2007 or (ii) the date of the Company's 2007 Annual Meeting of Stockholders.

5. The Stock Appreciation Rights were granted on April 18, 2007 and vest on the earlier of (i) April 18, 2008 or (ii) the date of the Company's 2008 Annual Meeting of Stockholders.

6. Restricted Stock Units do not have an expiration date.

7. The Restricted Stock Units were granted on April 8, 2008 and vest in the incremental amount of 33% on the earlier of (i) April 8, 2009 or (ii) the date of the Company's 2009 Annual Meeting of Stockholders; 34% on the earlier of (i) April 8, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 8, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders. The Restricted Stock Units settle on the date of the director's termination of service with the Company.

8. The Stock Appreciation Rights were granted on April 8, 2008 and vest on the earlier of (i) April 8, 2009 or (ii) the date of the Company's 2009 Annual Meeting of Stockholders.

9. The Restricted Stock Units were granted on April 9, 2009 and vest in the incremental amount of 33% on the earlier of (i) April 9, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders; 34% on the earlier of (i) April 9, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 9, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders. The Restricted Stock Units settle on the date of the director's termination of service with the Company.

10. The Stock Appreciation Rights were granted on April 9, 2009 and vest on the earlier of (i) April 9, 2010 or (ii) the date of the Company's 2010 Annual Meeting of Stockholders.

11. The Restricted Stock Units were granted on April 13, 2010 and vest in the incremental amount of 33% on the earlier of (i) April 13, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; 34% on the earlier of (i) April 13, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 13, 2013 or (ii) the date of the Company's 2013 Annual Meeting of Stockholders. The Restricted Stock Units settle on the date of the director's termination of service with the Company.

12. The Stock Appreciation Rights were granted on April 13, 2010 and vest on the earlier of (i) April 13, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders.

13. The Restricted Stock Units were granted on April 12, 2011 and vest on the earlier of (i) April 12, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders.

14. Common Stock acquired on the vesting of Restricted Stock Units.

	Douglas D Wheat	04/12/2012
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.